Status:
RECRUITING
Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure
Lead Sponsor:
Aether Tech S.L.
Collaborating Sponsors:
Hospital Universitario Fundación Jiménez Díaz
Hospital Clinic of Barcelona
Conditions:
Chronic Respiratory Failure
Acute Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Currently, there is no holistic solution for patients with respiratory diseases that includes oxygenation and management of a patient with respiratory disease, combining dynamic and automatic O2 admin...
Detailed Description
There is no doubt about the efficacy of oxygen therapy in the treatment of acute and chronic respiratory failure in different clinical settings. However, its therapeutic dosage is not as strict as tha...
Eligibility Criteria
Inclusion
- Men and women over 18 years of age.
- Admitted to intermediate respiratory care unit with a diagnosis of acute respiratory failure for at least 8 hours.
- Informed consent understood and signed.
Exclusion
- Hemodynamic instability.
- Severe temperature changes.
- Hemoglobinopathies, severe anemia, severe acidosis, or severe alkalosis.
- Anatomical disturbances.
- Pregnancy or breastfeeding.
Key Trial Info
Start Date :
April 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06952816
Start Date
April 23 2025
End Date
December 30 2026
Last Update
January 9 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
2
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain